VaccineMaitri reaffirms highest priority accorded by India to relations with Bangladesh

New Delhi, Jan 25: Bangladesh turned to India for the supply of the Serum Institute of India’s Covishield vaccine, after Beijing asked Dhaka to share costs of clinical trials of Sinovac.

India is clearly gaining the edge over China when it comes to vaccine diplomacy. Free shipments containing the first batch of Covishield which is manufactured by the Serum Institute of India have already reached many nations. 2 million doses were supplied to Bangladesh, while 1 million was given to Nepal as a gift under the Neighbourhood First Policy.

Read more